Endothelial Biomarkers Are Superior to Classic Inflammatory Biomarkers in Community-Acquired PneumoniaBIOMEDICINESIF3.92024-10-210OAAI
Understanding the Host in the Management of Pneumonia An Official American Thoracic Society Workshop Report了解肺炎管理中的主持人美国胸科学会官方研讨会报告ANNALS OF THE AMERICAN THORACIC SOCIETYIF5.42021-07-0114OAAI
Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact ofPseudomonas aeruginosaJOURNAL OF CLINICAL MEDICINEIF2.92020-08-1327OAAI
Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortalityJOURNAL OF INFECTIONIF11.92019-06-0147PREAI
Platelet activation is boosted early in community-acquired pneumonia and sustained until 30 days laterEUROPEAN RESPIRATORY JOURNALIF212018-11-192PRE
Initial Inflammatory Profile in Community-acquired Pneumonia Depends on Time since Onset of SymptomsAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42018-08-0140OAAI
Interpretation of biomarkers at emergency department depends on onset of symptoms in community-acquired pneumoniaEUROPEAN RESPIRATORY JOURNALIF212017-12-061PRE
Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbationsBMC INFECTIOUS DISEASESIF32017-09-3024OAAI
Chronic inhaled corticosteroids in patients with bronchiectasis who suffer an exacerbationEUROPEAN RESPIRATORY JOURNALIF212016-11-080PRE
Biomarkers and cardiovascular events in community-acquired pneumoniaEUROPEAN RESPIRATORY JOURNALIF212016-11-080PRE
Pneumonia presenting with organ dysfunctions: Causative microorganisms, host factors and outcomeJOURNAL OF INFECTIONIF11.92016-11-0123PREAI
Age-related risk factors for bacterial aetiology in community-acquired pneumoniaRESPIROLOGYIF6.32016-07-1428PREAI